Three psychoactive arylcyclohexylamines, advertised as "research chemicals," were obtained from an online retailer and characterized by gas chromatography ion trap electron and chemical ionization mass spectrometry, nuclear magnetic resonance spectroscopy and diode array detection. The three phencyclidines were identified as 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexanone (methoxetamine), N-ethyl-1-(3-methoxyphenyl)cyclohexanamine and 1-[1-(3-methoxyphenyl)cyclohexyl]piperidine. A qualitative/quantitative method of analysis was developed and validated using liquid chromatography (HPLC) electrospray tandem mass spectrometry and ultraviolet (UV) detection for the determination of these compounds in blood, urine and vitreous humor. HPLC-UV proved to be a robust, accurate and precise method for the qualitative and quantitative analysis of these substances in biological fluids (0.16-5.0 mg/L), whereas the mass spectrometer was useful as a confirmatory tool.
Introduction
The dissociative anaesthetic 1-(1-phenylcyclohexyl)piperidine (PCP) has served as a classic pharmacological tool in the search for an understanding of the mechanisms involved in several psychiatric conditions that appear to involve the N-methyl-D-aspartate class of glutamate receptors (1 -3) . Analogues and derivatives based on the arylcyclohexylamine backbone have formed the basis of conventional drug discovery and drug development, although some new drugs have occasionally originated from clandestine laboratories (4, 5) . Very recently, many less well characterized arylcyclohexylamines have appeared on the market as "research chemicals," which can be obtained from internet retailers. Examples include 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexanone (methoxetamine, MXE or 3-MeO-2-Oxo-PCE), N-ethyl-1-(3-methoxyphenyl)cyclohexanamine (3-methoxyeticyclidine or 3-MeO-PCE) and 1-[1-(3-methoxyphenyl) cyclohexyl]piperidine (3-methoxyphencyclidine or 3-MeO-PCP) ( Figure 1A ) (6) (7) (8) (9) (10) . Data on the prevalence of use of these substances is limited, but reports of acute MXE intoxications, with or without analytical confirmation, have recently appeared (11) (12) (13) (14) (15) (16) (17) , including one report of a fatal intoxication (17) .
The present study aimed to identify three products, sold separately on the internet as "research chemicals," and advertised as containing MXE, 3-MeO-PCE and 3-MeO-PCP. Analytical characterization was conducted by gas chromatography (GC) ion trap electron and chemical ionization (EI/CI) mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR).
Although MXE has received some attention across various platforms (18, 19) little is known about 3-MeO-PCE and 3-MeO-PCP. To allow detection in postmortem samples, a qualitative/quantitative assay for the determination of these three novel recreational substances was developed and validated in blood, urine and vitreous humor using high-performance liquid chromatography with ultraviolet detection (HPLC -UV) coupled to electrospray (ESI) hybrid triple-quadrupole linear ion trap tandem MS.
Materials and Methods
All solvents and chemicals were of analytical grade or equivalent and were purchased from Aldrich (Dorset, UK) unless stated otherwise. Test samples of MXE (nominal mass 247 Da), 3-MeO-PCE (nominal mass 233 Da) and 3-MeO-PCP (nominal mass 273 Da) were purchased online in March of 2012.
GC-MS characterization
GC-EI/CI-MS spectra (scan range m/z 40 -350) were obtained on a Varian 450-GC gas chromatograph coupled to a Varian 220-MS ion trap mass spectrometer (Varian, Walnut Creek, CA). Samples were introduced by using a Varian 8400 autosampler and a CP-1177 injector (2808C) in split mode (1:50). Data manipulation was conducted with the MS Data Review function of the Workstation software, version 6.91. Transfer line, manifold and ion trap temperatures were set at 280, 80 and 2208C, respectively. The liquid CI reagent was HPLC grade methanol. CI ionization parameters (0.4 s/scan): CI storage level, 19.0 m/z; ejection amplitude, 15.0 m/z; background mass, 55 m/z; maximum ionization time, 2,000 ms; maximum reaction time, 40 ms; target TIC, 5,000 counts. A 30 m Â 0.25 mm (0.25 mm film thickness) Supelco SLB-5ms GC column (Bellefonte, PA) was employed for separation. The temperature profile started at 808C, was held for 1 min and raised, at a rate of 208C/min, to 2808C and held constant for 9 min, leading to a total run time of 20 min.
LC-MS quantitative/qualitative determination
Instrumentation Quantitative/qualitative analyses in blood (Blood Transfusion Service, Ninewells NHS hospital, Dundee, UK), vitreous (removed from porcine eyes purchased from the local butcher) and urine (from members of the laboratory staff ) were performed with a 1200 Agilent HPLC-DAD system interfaced to an Applied Biosystems 3200 Q TRAP triple-quadrupole linear ion trap mass spectrometer (AB Applied Biosystems, Foster City, CA) equipped with an electrospray ionization source (ESI). Data were obtained by the Analyst 1.5 software. A Phenomenex Synergi Fusion C18 column (50 Â 2 mm Â 4 mm) with a Phenomenex Synergi Guard column (Macclesfield, UK) was used for chromatographic separation. Mobile phase A consisted of 1 mM ammonium formate with 0.1% formic acid and mobile phase B was 50% acetonitrile (ACN) with 1 mM ammonium formate and 0.1% formic acid (ammonium formate, formic acid and HPLC-grade ACN were from Aldrich, Poole, UK). Compound elution was conducted under isocratic conditions with 12.5% ACN (25% phase B). The flow rate was 0.7 mL/min; injection time was 10 s; column temperature was 408C; total run time was 6 min. The ion source was set in positive mode and the ions formed scanned by multiple reaction monitoring (MRM) along with the information-dependent enhanced product ion (EPI) function. EPI scans were performed for a scan range between m/z 45 and 800 (scan rate 1,000 amu/s) with collision energy ( 
Sample preparation
Working standard solutions and quality control solutions were 1,000 mg/L MXE, 3-MeO-PCP and 3-MeO-PCE (LGC Promochem, Teddington, UK) in water, and brompheniramine 4 mg/L in 0.2M Na 2 CO 3 , pH 10 (Aldrich) as the (IS). The method was validated in blank blood, water (used for quantitation in vitreous humor) and urine. The extraction was performed according to a previously published method (27) . Each sample matrix (0.5 mL) was fortified with 0.5 mL of the IS and extracted with 5 mL of 1-chlorobutane (Fisher Scientific; Loughborough, UK). Following centrifugation (3,000 rpm for 5 min), the top solvent layer was retro-extracted with 100 mL of 0.05M H 2 SO 4 (Aldrich) and the extracted acid solution was transferred to a vial for injection.
Method validation
The limit of quantitation (LOQ) was set at 0.16 mg/L for all matrices and all three analytes, followed by the preparation of calibration curves at six concentration levels of 0.16, 0.31, 0.62, 1.25, 2.5 and 5 mg/L. The limit of detection (LOD) was calculated as three times the standard error at the intercept from linear regression. Intra-day and inter-day accuracy and precision were determined using quality control samples of the compounds in the different matrices at concentrations of 0.5 (low quality control: LQC) and 2 mg/L (high quality control: HQC). These samples were analyzed in five replicates on three different days with each sample run in triplicate.
UV scan data were employed for qualitative and quantitative purposes, whereas MS data were used for mass spectral characterizations and confirmatory purposes. For diode array detection (DAD) full scan analyses, a scan range between 190 and 400 nm was chosen for all three substances, whereas a single wavelength of 205 nm was utilized for quantitative purposes. Recovery values were calculated comparing the slope of the calibration curves of standards prepared in sulphuric acid solution (0.05M) and blood, urine and water. Blood and urine concentrations of MXE, 3-MeO-PCE and 3-MeO-PCP were calculated by using a calibration curve in the same matrix. In the case of vitreous humor, water was used for the construction of the calibration curve. To evaluate possible matrix differences between water and vitreous humor, preserved (sodium fluoride/potassium oxalate) porcine vitreous samples were spiked with the three analytes at different concentrations, extracted and measured against the water calibration curve to evaluate the percentage error.
Data and Results
NMR characterization of analytes NMR spectra were obtained on a Bruker Avance 300 spectrometer (Coventry, UK) at 300. Figure 1 provides a summary of mass spectral features associated with MXE, 3-MeO-PCE and 3-MeO-PCP. The corresponding EI and CI ion trap (IT) mass spectra are shown in Figures 1A1-A3 , which were obtained from sample introduction by GC. Under EI-IT-MS conditions, the base peak of MXE ( Figure 1A1) was represented by what appeared to be the protonated molecule, presumably due to ion -molecule reactions within the IT. The corresponding CI-IT-MS displayed the associated protonated molecules and some form of dissociation ( Figures 1A4 -A6 ). In cases of 3-MeO-PCE and 3-MeO-PCP, for example, a prominent deamination species was observed (m/z 189). Interestingly, an equivalent fragment was not observed for MXE under these conditions, which may relate to the presence of the cyclohexanone ring rather than the cyclohexane species.
GC-EI/CI-MS characterization of analytes
The ESI triple-quadrupole linear IT-MS-MS data for all three analytes are shown in Figures 1B1-B3 . A commonality between 3-MeO-PCE and 3-MeO-PCP was the formation of the deaminated m/z 189 ion; in addition, the substituted tropylium species (m/z 121) was equally observed (Figures 1B2 and B3) . The m/z 86 fragment observed in the MS-MS of 3-MeO-PCP may represent the protonated piperidine, but the extent, if any, to which the protonated ethylamine counterpart was formed (3-MeO-PCE) could not be determined because this m/z value fell below the scan range, which started from m/z 50. The two most abundant product ions observed for MXE were detected at m/z 203 and 175 and may represent deamination followed by the loss of CO ( Figure 1B1) . A representative LC-ESI-MS-MS trace that shows an analysis of a standard mixture, including brompheniramine as the IS, is shown in Figure 1C .
LC-MS Method Validation
Quantitative analysis was conducted in spiked unpreserved whole blood, urine and water based on the constructed calibration curves at six concentration levels. The calibration curves were based on height ratios of the analyte peak to the height of the IS peak.
Blood HPLC-UV calibration curves were linear in the range between 0.16 and 5.0 mg/L. Intra-day and inter-day precision [ percentage relative standard deviation (RSD, %)] and accuracy (bias, %), LOD and LOQ results are summarized in Table I . Overall, these results satisfied the acceptance criteria for precision (within 15% RSD) and accuracy (bias within + 15% of the accepted reference value) (20) . Interfering peaks were not observed during the analysis of a series of blood samples, although a system peak at 0.72 min was present in all blood samples (Figure 2A ). Due to complete separation, this peak did not interfere with the quantitation of MXE at 0.93 min (Figure 2A ). The extracted samples were observed to be stable for at least 24 h when stored at 58C (response was measured against the calibration curve from the previous day) and recovery values for MXE, 3-MeO-PCE and 3-MeO-PCP were above 87%. The DAD full scan spectra for all analytes including the internal standard are summarized in Figure 2B .
Water (for quantitation in vitreous humor) HPLC-UV calibration curves were linear in the range between 0.16 and 5.0 mg/L. Intra-day and interday precision (RSD) and accuracy (bias) results are summarized in Table I . No interfering peaks were observed during the analysis of vitreous samples. Extracted samples were stable for at least 24 h when stored at 58C. The recovery of MXE, 3-MeO-PCE and 3-MeO-PCP was greater than 98%.
To evaluate matrix differences between water and vitreous humor preserved (fluoride/oxalate) porcine humor, vitreous samples were spiked with the three analytes at different concentrations within the range of the calibration curve (0.625, 1.25, 2.0, 2.5 and 4 mg/L), extracted and measured against a water calibration curve. All spiked concentrations ranged between 0.8 and 6.7% for MXE, 0.25 and 3% for 3-MeO-PCE and 0.5 and 3.6% for 3-MeO-PCP of the expected values. Consequently, these values were deemed to be acceptable for the determination of vitreous concentrations based on a water calibration curve.
Urine HPLC-UV calibration curves were linear in the range between 0.16 and 5.0 mg/L. Intra-day and inter-day precision (RSD) and accuracy (bias) results are summarized in Table I . No interfering peaks were observed. The extracted samples were stable for at least 24 h when stored at 58C. The recovery of MXE, 3-MeO-PCE and 3-MeO-PCP was greater than 98%. 
Inter-day (blood and water, n ¼ 15; urine, n ¼ 12) 
Discussion
The 1 H and 13 C NMR spectra for the three compounds were consistent with the existing literature reports for MXE ( 1 H and 13 C), 3-MeO-PCP ( 13 C) and related arylcyclohexylamines (7, 15, 21, 22) . In the 1 H NMR spectra, all three compounds gave a large singlet at approximately 3.85 ppm, integrating to three protons consistent with the three protons of the methoxy substitution. Likewise, the downfield aromatic region of the 1 H spectra was consistent with meta-aromatic substitution and the occurrence of four distinct chemical shifts. Both short and long range coupling constants were observed between these aromatic protons and were largely consistent between the three compounds. spectra revealed the presence of dd in the aromatic region, whereas two ddd splittings were observed in the present study. When inspecting the 1 H/ 13 C correlations heteronuclear single quantum coherence spectroscopy (HSQC), it was interesting to observe that all four cylohexanone-related methylene carbon chemical shifts present in the 13 C spectrum of MXE revealed 1 H correlations with distinctive chemical shifts, which meant that the methylene proton signals were split into different shift values and integrals. This phenomenon, also observed with 3-MeO-PCE and 3-MeO-PCP, was a consequence of distinctive proton shift values for axial-equatorial protons typically observed for PCP-type substances (23, 24) . 13 C spectra were consistent with those reported previously for MXE HCl and 3-MeO-PCP HCl (7, 22) . As expected, all OCH 3 carbon chemical shift values observed for all three substances were at approximately 56.0 ppm, which is consistent with literature reports (7, 22) .
The observation of an m/z 248 base peak detected for MXE ( Figure 1A1 ) is consistent with a previous study that utilized an IT-MS under EI conditions (15) . It is noteworthy that the relative abundance of key fragments (m/z 91, 121, 134, 147, 160, 176, 190, 219) differed when the mass spectrum was generated using quadrupole instrumentation, i.e., they appeared to be generally more abundant than the spectrum derived from the IT instrument (data not shown). Under these conditions, the base peak was detected at m/z 190 and the M þ at m/z 247 only showed minor abundance levels, which is in agreement with the spectrum reported by Hays et al. (7) . By contrast, the EI-IT-MS spectra observed for 3-MeO-PCE and 3-MeO-PCP reported here ( Figures 1A2 and A3) showed a higher degree of similarity when compared to EI-quadrupole MS analysis (not shown). A proposed fragmentation pattern for MXE has been suggested (7), and fragment formation for 3-MeO-PCE and 3-MeO-PCP appears to essentially follow the patterns reported for their unsubstituted counterparts, PCE (25) and PCP (26, 27) .
HPLC-based separations revealed that all four components could be conveniently separated within 5 min. LC-ESI-MS-MS, which was used as a qualitative and quantitative tool, allowed for the determination of the three most responsive ion transitions and the associated ion ratios ( Figure 1C) ; this may be particularly useful for quality control purposes. An additional advantage of the obtained ion ratios may also arise when dealing with positional isomers, especially in the absence of reference material, and further studies will be useful once the corresponding isomers become commercially available. One of the three ion transitions determined for MXE (m/z 248 . 203) has very recently been employed for an LC-ESI-IT-MS-MS based detection of MXE in human plasma following non-lethal acute intoxication (16) , whereas the same three ion transitions have recently been described (17) .
Currently, data are not available in the literature on lethal concentrations of 3-MeO-PCE and 3-MeO-PCP in biological matrices. Consequently, the current choice of quantitation levels, i.e., concentration levels used for the construction of calibration curves, were based on what might be considered to be the lower range of toxic ketamine concentrations. Postmortem blood and urine levels of ketamine in ketamine overdoses have been reported to range between 1.5 and 8.5 mg/L (28), but data are not available for vitreous humor. Allowing for a potential difference in potency between ketamine and the arylcyclohexylamines investigated in this study, it was decided to create a calibration range of 0.16 -5.0 mg/L.
In the initial phase of development for the quantitative method for MXE, 3-MeO-PCE and 3-MeO-PCP by LC-MS it was decided to use the corresponding MRM transitions for quantitation purposes. The concentration range chosen for the calibration curve (based on toxic levels of ketamine reported in literature) did not show satisfactory linearity for all three compounds in aqueous solution or biological matrices. The MS was found to give a saturated detector response for all analytes, which reflected a high degree of ionization. To overcome this problem, UV detection was used. In this way, the DAD was used for qualitative and quantitative purposes, whereas the MS served as a confirmatory tool. This approach proved to be practicable because all assessed method validation parameters were found to be within acceptable QC limits for all three investigated matrices and substances.
There have been several very recent reports on the levels of MXE observed in cases of acute intoxication and most of the reported levels fall within the calibration range used in the present study. Plasma levels of MXE, determined by GC-MS, were 0.09, 0.12 and 0.20 mg/L (12) and 0.16, 0.24 and 0.45 mg/L (14), but methodological details and validation parameters were not provided. A fully validated TurboFlow LC-ESI-IT-MS-MS method for MXE was recently described, with a reported plasma concentration of 0.136 mg/L following MXE ingestion. A powder sample associated with the case was found to consist of 35% MXE and 20% acetaminophen (paracetamol) (16) . A Swedish study detailed the LC-ESI-MS-MS detection of MXE in whole blood, with four acute intoxications levels ranging from 0.13 to 0.49 mg/g and one fatality with a level of 8.6 mg/g in postmortem femoral blood, together with prescription drugs and cannabinoids (17) .
The extent to which the ( psycho)pharmacological profiles of the three substances reported in the present study show similarities to PCP/ketamine-type substances remains to be investigated in more detail, but there appear to be some pharmacological overlaps (29 -32) . During the course of this investigation, the UK Advisory Council on the Misuse of Drugs (ACMD) published a recommendation to place MXE and related substances under control, by way of a generic definition, via amendment of the Misuse of Drugs Act 1971 (Class B) and the Misuse of Drugs Regulations (2001) (Schedule 1) which came into effect in February 2013 (32) .
Conclusions
The ability to qualitatively and quantitatively detect newly emerging psychoactive substances forms an increasingly important part of contemporary analytical toxicological work. The present study showed that it is feasible to reliably determine the presence of MXE, 3-MeO-PCE and 3-MeO-PCP in blood, urine and vitreous humor. HPLC-DAD offers a robust method for the qualitative and quantitative analysis of these substances in biological fluids and the MS provides a useful confirmatory tool.
